A pharmacogenetic study of docetaxel and thalidomide in patients with androgen-independent prostate cancer (AIPC) using targeted human DMET genotyping platform
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: National Cancer Institute
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2249392395
